By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

QLT Inc. 

887 Great Northern Way

Vancouver  British Columbia  V5T 4T5  Canada
Phone: n/a Fax: 604-707-7001


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals

Collaborations

Kinetek Pharmaceuticals Inc. 





Company News
QLT Inc. (QLTI) Announces Results Of Annual General Meeting Of Shareholders 12/16/2014 8:01:19 AM
QLT Inc. (QLTI) Announces Results From Proof-of-Concept Trial With Oral Synthetic Cis-Retinoid (QLT091001) In Adult Subjects With Impaired Dark Adaptation And/Or Impaired Low Luminance Vision 12/5/2014 8:55:00 AM
QLT Inc. (QLTI) Announces Departure Of Chief Financial Officer 12/2/2014 11:52:36 AM
QLT Inc. (QLTI) Announces Third Quarter 2014 Results 10/28/2014 7:04:17 AM
QLT Inc. (QLTI) Appoints Dr. Geoffrey F. Cox As Interim CEO 10/24/2014 6:51:37 AM
QLT Inc. (QLTI) Announces Merger With Auxilium Pharmaceuticals (AUXL) Terminates For Superior Proposal 10/9/2014 7:41:28 AM
Endo International plc (ENDP) Pays $2.6 Billion For Auxilium Pharmaceuticals (AUXL), Auxilium Drops QLT Inc. (QLTI) Deal 10/9/2014 6:02:12 AM
Auxilium Pharmaceuticals (AUXL) Rejects $2.2B Bid From Endo International plc (ENDP), While QLT Inc. (QLTI) Merger Looks More Likely 9/22/2014 6:29:27 AM
QLT Inc. (QLTI) Provides Update On Merger With Auxilium Pharmaceuticals (AUXL) 9/17/2014 7:51:17 AM
QLT Inc. (QLTI) Announces Positive Final Results From Phase 1b Retreatment Trial With Oral Synthetic Cis-Retinoid (QLT091001) In Subjects With LCA Or RP Due To Mutations In RPE65 Or LRAT 9/12/2014 10:41:27 AM
12345678910...
//-->